Allogenic CAR cytokine induced killer cell therapy (CoImmune Inc)

N/A

Report date: 2025/01/26 19:11:37

Base Information

Drug NameAllogenic CAR cytokine induced killer cell therapy (CoImmune Inc)
Drug Alias NameCAR cytokine induced killer cell therapy (CoImmune Inc)CAR-CIK cell therapy (CoImmune Inc)CAR T-cell therapy (CoImmune Inc)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell > Chimeric antigen receptor CIK cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionT lymphocytes stimulantsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoImmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesCoImmune Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A